- Home
- SLBT vs XPEL Comparison
SLBT vs XPEL Comparison
Compare SLBT & XPEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SLBT | XPEL |
|---|---|---|
| Founded | N/A | 1999 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | SLBT | XPEL |
|---|---|---|
| Price | $2.10 | $47.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $56.00 |
| AVG Volume (30 Days) | 46.5K | ★ 149.1K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 12.12 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | ★ $476,200,000.00 |
| Revenue This Year | N/A | $12.64 |
| Revenue Next Year | N/A | $11.98 |
| P/E Ratio | ★ N/A | $47.37 |
| Revenue Growth | N/A | ★ 13.27 |
| 52 Week Low | $2.51 | $31.50 |
| 52 Week High | $6.25 | $55.91 |
Technical Indicators
Market Signals| Indicator | SLBT | XPEL |
|---|---|---|
| Relative Strength Index (RSI) | 33.37 | 44.20 |
| Support Level | N/A | $45.60 |
| Resistance Level | $3.36 | $49.41 |
| Average True Range (ATR) | 0.25 | 1.38 |
| MACD | -0.01 | -0.38 |
| Stochastic Oscillator | 2.67 | 12.87 |
Price Performance
Historical ComparisonAbout SLBT SL Science Holding Limited Ordinary Shares
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.
About XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services principally to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from Product, which includes Paint protection film and Window film. The company derives revenue from Service, which includes Software, Cutbank credits, and Installation labor. The majority of revenue is derived from the United States.